Novartis Faces Strict Pharmacy Oversight In $390M Deal
By Jeff Overley · November 20, 2015, 8:12 PM EST
Novartis on Friday made detailed admissions about its sales strategies with specialty pharmacies and agreed to sweeping federal oversight of its relationships with the controversial dispensers, capping off a mammoth False...
To view the full article, register now.